Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials Meeting Abstract
| Authors: | Barrientos, J. C.; Ghia, P.; Pagel, J.; Salles, G. A.; Sharman, J. P.; Stilgenbauer, S.; Gurtovaya, O.; Kim, Y.; Philip, B.; Zelenetz, A. D. |
| Abstract Title: | Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901875 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.8563 |
| Notes: | Meeting Abstract: 8563 -- Source: Wos |
